NIRS-IVUS to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation (IMPACTavi)
NIRS-IVUS to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation; the IMPACTavi Trial
Sponsor: Deutsches Herzzentrum Muenchen
A observational or N/A phase clinical study on Aortic Stenosis, Severe and Coronary Artery Disease, this trial is ongoing. The trial is conducted by Deutsches Herzzentrum Muenchen and has accumulated 6 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Feb 2025 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2022 — Jul 2024 [monthly]
Recruiting
▶ Show 1 earlier version
-
Sep 2021 — Dec 2022 [monthly]
Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsches Herzzentrum Muenchen
- Infraredx Inc
For direct contact, visit the study record on ClinicalTrials.gov .